Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption

Transfusion

Volumn 49, Issue 4, 2009, Pages 711-718

  Arndt, Patricia ^a   Garratty, George ^b   Isaak, Edahn ^b   Bolger, Michael ^b   Lu, Qun ^b  

^a AMERICAN RED CROSS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN ANTIBODY; BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DRUG ANTIBODY; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADSORPTION; ADULT; AGED; ANTIBODY TITER; ARTICLE; ASSAY; AUTOIMMUNE HEMOLYTIC ANEMIA; CANCER CHEMOTHERAPY; CASE REPORT; CHILL; COLON ADENOCARCINOMA; COLON CANCER; COOMBS TEST; CROSS REACTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HEMICOLECTOMY; HUMAN; MONOCYTE MONOLAYER ASSAY; MULTIPLE CYCLE TREATMENT; NAUSEA; RECURRENT CANCER; SEROLOGY; SERUM; VOMITING;

ADENOCARCINOMA; ADSORPTION; AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; COOMBS' TEST; DRUG INTERACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PROTEINS;

EID: 62949168427     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.02028.x     Document Type: Article

References (29)

1. Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia (PA) : Churchill Livingstone 2004.
2. Getaz EP, Beckley S, Fitzpatrick J, Dozier A. Cisplatin-induced hemolysis. N Engl J Med 1980 302 : 334 5.
3. Cinollo G, Dini G, Franchini E, Lanino E, Sindaco F, Garaventa A. Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin. Cancer Chemother Pharmacol 1988 21 : 85 6.
4. Zeger G, Smith L, McQuiston D, Goldfinger D. Cisplatin-induced nonimmunologic adsorption of immunoglobulin by red cells. Transfusion 1988 28 : 493 5.
5. Arndt PA, Garratty G, Isaak E, Bolger MJ. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be caused by antibody and/or nonimmunologic protein adsorption [abstract Transfusion 2003 43 : 102A.
6. Spath P, Garratty G, Petz LD. Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin administration. J Immunol 1971 107 : 860 9.
7. Garratty G, Arndt PA. Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells. Br J Haematol 1998 100 : 777 83.
8. Desrame J, Broustet H, Darodes de Tailly P, Girard D, Saissy JM. Oxaliplatin-induced haemolytic anaemia. Lancet 1999 354 : 1179 80.
9. Garufi C, Vaglio S, Brienza S, Conti L, D'Attino RM, Girelli G, Terzoli E. Immunohemolytic anemia following oxaliplatin administration. Ann Oncol 2000 11 : 497.
10. Earle CC, Chen WY, Ryan DP, Mayer RJ. Oxaliplatin-induced Evan's syndrome. Br J Cancer 2001 84 : 441.
11. Sorbye H, Bruserud O, Dahl O. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis. Acta Oncol 2001 40 : 882 3.
12. Chen VM, Thrift KM, Morel-Kopp M-C, Jackson D, Ward CM, Flower RL. An immediate hemolytic reaction induced by repeated administration of oxaliplatin. Transfusion 2004 44 : 838 43.
13. Hofheinz RD, Nguyen XD, Buchheidt D, Kerowgan M, Hehlmann R, Hochhaus A. Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient. Cancer Chemother Pharmacol 2004 53 : 276 7.
14. Koutras AK, Makatsoris T, Paliogianni F, Kopsida G, Onyenadum A, Gogos CA, Mouzaki A, Kalofonos HP. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis. Oncology 2004 67 : 179 82.
15. Taleghani BM, Fontana S, Meyer O, Ahrens N, Novak U, Borner MM, Salama A. Oxaliplatin-induced immune pancytopenia. Transfusion 2005 45 : 704 8.
16. Le BH, Juneja S, Gibbs P. Hemolysis and thrombocytopenia following oxaliplatin administration. Asia Pac J Clin Oncol 2005 1 : 57 60.
17. Noronha V, Burtness B, Murren J, Duffy TP. Oxaliplatin induces a delayed immune-mediated hemolytic anemia: a case report and review of the literature. Clin Colorectal Cancer 2005 5 : 283 6.
18. Johnson ST, Fueger JT, Gottschall JL. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia. Transfusion 2007 47 : 697 702.
19. Buti S, Ricco M, Chiesa MD, Copercini B, Tomasello G, Brighenti M, Passalacqua R. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report. Anticancer Drugs 2007 18 : 297 300.
20. Cobo F, De Celis G, Pereira A, Latorre X, Pujadas J, Albiol S. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature. Anticancer Drugs 2007 18 : 973 6.
21. Garratty G, Houston M, Petz LD, Webb M. Acute immune intravascular hemolysis due to hydrochlorothiazide. Am J Clin Pathol 1981 76 : 73 8.
22. a. Transfusion 1984 24 : 206 9.
23. Shirey RS, Morton SJ, Lawton KB, Lowell C, Kickler TS, Ness PM. Fenoprofen-induced immune hemolysis: difficulties in diagnosis and complications in compatibility testing. Am J Clin Pathol 1988 89 : 410 14.
24. Brecher ME, editor. Technical manual. 15th ed. Bethesda : American Association of Blood Banks 2005.
25. Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987 27 : 449 52.
26. Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004 44 : 1273 81.
27. Arndt P, Garratty G. Is severe immune hemolytic anemia, following a single dose of cefotetan, associated with the presence of "naturally- occurring" anti-cefotetan? [abstract Transfusion 2001 41 : 24S.
28. Broadberry RE, Farren TW, Bevin SV, Kohler JA, Yates S, Skidmore I, Poole J, Garratty G. Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient's red cells. Transfus Med 2004 14 : 53 7.
29. Arndt P, Garratty G. Can nonspecific protein coating of RBCs lead to increased RBC destruction? Drug-treated RBCs with positive antiglobulin tests due to nonspecific protein uptake give positive monocyte monolayer assays [abstract Transfusion 2000 40 : 119S.